These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 3135739
41. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia. Sager PT, Widerhorn J, Petersen R, Leon C, Ryzen E, Rude R, Rahimtoola SH, Bhandari AK. Am Heart J; 1990 Feb; 119(2 Pt 1):308-16. PubMed ID: 2301220 [Abstract] [Full Text] [Related]
42. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing. Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M. Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994 [Abstract] [Full Text] [Related]
43. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia]. Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L. Z Kardiol; 1989 Oct 20; 78(10):640-6. PubMed ID: 2686251 [Abstract] [Full Text] [Related]
44. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia. Naccarelli GV, Jackman WM, Akhtar M, Rinkenberger RL, Friday KJ, Dougherty AH, Tchou P, Yeung-Lai-Wah JA. Am J Cardiol; 1988 Dec 20; 62(19):31L-36L. PubMed ID: 3144165 [Abstract] [Full Text] [Related]
45. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia]. Brandão L, de Sousa J, Barreiros MC, Vagueiro MC, Amram SS. Rev Port Cardiol; 1994 Mar 20; 13(3):197-202, 191. PubMed ID: 8049086 [Abstract] [Full Text] [Related]
46. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm. Crozier IG, Ikram H, Kenealy M, Levy L. Am J Cardiol; 1987 Mar 01; 59(6):607-9. PubMed ID: 3103410 [Abstract] [Full Text] [Related]
47. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias. Sahar DI, Reiffel JA, Bigger JT, Squatrito A, Kidwell GA. Am Heart J; 1989 Mar 01; 117(3):562-8. PubMed ID: 2919535 [Abstract] [Full Text] [Related]
48. Clinical, electrophysiologic and antiarrhythmic efficacy of moricizine HCl. Smetnev AS, Shugushev KKh, Rosenshtraukh LV. Am J Cardiol; 1987 Oct 16; 60(11):40F-44F. PubMed ID: 3310584 [Abstract] [Full Text] [Related]
49. [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia]. Vester EG. Herz; 1997 Jun 16; 22 Suppl 1():40-50. PubMed ID: 9333591 [Abstract] [Full Text] [Related]
50. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia. Sethi KK, Singh B, Kalra GS, Arora R, Khalilullah M. Indian Heart J; 1994 Jun 16; 46(3):141-4. PubMed ID: 7821934 [Abstract] [Full Text] [Related]
51. Electrophysiologic effects of ouabain in patients with preexcitation and circus movement tachycardia. Dhingra RC, Palileo EV, Strasberg B, Swiryn S, Bauernfeind R, Wyndham C, Rosen KM. Am J Cardiol; 1981 Jan 16; 47(1):139-44. PubMed ID: 7457399 [Abstract] [Full Text] [Related]
52. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes. Feld GK, Nademanee K, Weiss J, Stevenson W, Singh BN. J Am Coll Cardiol; 1984 May 16; 3(5):1298-307. PubMed ID: 6707383 [Abstract] [Full Text] [Related]
53. Long-term efficacy and safety of flecainide for supraventricular tachycardia. Neuss H, Schlepper M. Am J Cardiol; 1988 Aug 25; 62(6):56D-61D. PubMed ID: 3136637 [Abstract] [Full Text] [Related]
54. Treatment of refractory supraventricular arrhythmias with flecainide acetate. Till JA, Rowland E, Shinebourne EA, Ward DE. Arch Dis Child; 1987 Mar 25; 62(3):247-52. PubMed ID: 3105471 [Abstract] [Full Text] [Related]
55. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias. Fujiki A, Tani M, Mizumaki K, Shimono M, Inoue H. J Cardiovasc Pharmacol; 1994 Mar 25; 23(3):374-8. PubMed ID: 7515979 [Abstract] [Full Text] [Related]
56. Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndrome. Manolis AS, Estes NA. Am J Cardiol; 1989 Jul 15; 64(3):194-8. PubMed ID: 2500840 [Abstract] [Full Text] [Related]
57. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia]. Kühlkamp V, Mewis C, Mayer F, Seipel L. Z Kardiol; 1990 Oct 15; 79(10):725-31. PubMed ID: 2087860 [Abstract] [Full Text] [Related]
58. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH. Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636 [Abstract] [Full Text] [Related]
59. First postpacing interval after tachycardia entrainment with correction for atrioventricular node delay: a simple maneuver for differential diagnosis of atrioventricular nodal reentrant tachycardias versus orthodromic reciprocating tachycardias. González-Torrecilla E, Arenal A, Atienza F, Osca J, García-Fernández J, Puchol A, Sánchez A, Almendral J. Heart Rhythm; 2006 Jun 25; 3(6):674-9. PubMed ID: 16731468 [Abstract] [Full Text] [Related]
60. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia. Belhassen B, Glick A, Laniado S. Circulation; 1988 Apr 25; 77(4):795-805. PubMed ID: 3349581 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]